The active substance of the drug is meldonium. The action of the drug is
to prevent accumulation of cytotoxic intermediate products of fatty
acid beta-oxidation in ischemic tissues and to block this highly
oxygen-consuming process. Mildronate has a beneficial effect on cerebral
circulation disorders and central nervous system functions. Mildronate
is prescribed for patients with decreased working efficiency.